Thrombosis News and Research

Latest Thrombosis News and Research

Tablet splitting leads to inaccurate dosages

Tablet splitting leads to inaccurate dosages

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

New era for anticoagulant therapy

New era for anticoagulant therapy

LFB receives positive review feedback for closing of Willfact 1000 IU Mutual Recognition Procedure

LFB receives positive review feedback for closing of Willfact 1000 IU Mutual Recognition Procedure

REVA raises A$85 million through IPO

REVA raises A$85 million through IPO

BioInvent, Japanese pharmaceutical extends partnership for therapeutic candidate development

BioInvent, Japanese pharmaceutical extends partnership for therapeutic candidate development

Nose job gone horribly wrong

Nose job gone horribly wrong

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

STENTYS initiates international APPOSITION III self-apposing stent study in AMI patients

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

ART's stent superior than other bioresorbable stents

ART's stent superior than other bioresorbable stents

Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

Data from comparative REVLIMID study in multiple myeloma presented at 52nd ASH

New bio-coating technology could enhance long-term performance of medical implant devices

New bio-coating technology could enhance long-term performance of medical implant devices

Low dose of aspirin reduces occurrence of several common cancers: Study

Low dose of aspirin reduces occurrence of several common cancers: Study

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis evaluates association between hemolysis, mortality in patients with PNH

New analysis evaluates association between hemolysis, mortality in patients with PNH

No evidence of toxicity in hemophilia B patients enrolled in gene therapy trial

No evidence of toxicity in hemophilia B patients enrolled in gene therapy trial

New research focusing on VTE presented at ASH Annual Meeting

New research focusing on VTE presented at ASH Annual Meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.